Here are six things to know:
1. The two companies will enter into a definitive settlement agreement within 15 days.
2. NuVasive and Medtronic agreed on the settlement terms of patent infringement lawsuits stemming from 2008.
3. NuVasive will make a one-time payment of $45 million to Medtronic and some of its subsidiaries.
4. The settlement releases both companies from any liabilities noted in the litigation.
5. NuVasive and Medtronic also agreed to halt patent litigation and instead, implement a dispute resolution process to deal with any patent infringement allegations in the future.
6. The settlement also offers both companies specific licenses for some products.
More articles on devices:
Amendia, Benvenue Medical, Zimmer Biomet & more: 15 key notes
Amendia names Chris Fair CEO: 4 points
Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
